Abstract
We describe a patient who developed bilateral oculomotor nerve palsy, ataxia, facial diplegia and lower limb weakness 2 weeks post-Oxford-AstraZeneca SARS-CoV2 vaccination, consistent with Miller-Fisher syndrome (MFS) and Guillain-Barre syndrome (GBS) overlap syndrome. Although some features of the patient’s presentation were typical of recently reported cases of a rare GBS variant post-Oxford-AstraZeneca vaccination, including severe facial weakness and a lack of respiratory involvement, to our knowledge this is the first reported case of MFS associated with SARS-CoV2 vaccination. While postvaccination GBS remains rare, it appears to have a favourable prognosis, and recognising this entity is therefore important for patient counselling and monitoring for potential complications.
Keywords: COVID-19; cranial nerves; neurology; peripheral nerve disease.
【저자키워드】 COVID-19, NEUROLOGY, cranial nerves, peripheral nerve disease, 【초록키워드】 SARS-CoV2, vaccination, Prognosis, knowledge, variant, NEUROLOGY, Patient, complications, disease, AstraZeneca, Guillain-barrè syndrome, Ataxia, peripheral nerve, lower limb, overlap syndrome, facial diplegia, limb weakness, overlap, syndrome, weakness, while, Fisher syndrome, postvaccination, feature, diplegia, Oculomotor nerve, lack, reported, the patient, appear, cranial, facial, 【제목키워드】 Patient, SARS-CoV-2 vaccination, Oxford-AstraZeneca, overlap,